Zenith Drugs Limited (NSE:ZENITHDRUG)

Market Cap	1.08B
Revenue (ttm)	1.33B
Net Income (ttm)	71.61M
Shares Out	17.15M
EPS (ttm)	4.18
PE Ratio	15.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8,160
Open	n/a
Previous Close	83.25
Day's Range	n/a
52-Week Range	47.15 - 112.95
Beta	n/a
RSI	44.31
Earnings Date	Nov 14, 2025

About Zenith Drugs

Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated i...

• Industry: Pharmaceutical Preparations
• Founded: 1956
• Employees: 182
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ZENITHDRUG

Financial Performance

In 2024, Zenith Drugs's revenue was 1.33 billion, an increase of 1.29% compared to the previous year's 1.32 billion. Earnings were 71.61 million, a decrease of -24.92%.